ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Barry Pierce New DCCP Chairman; Adamson Seeks Ads For Chemical, Biological Carcinogenesis

June 17, 1983

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009

ACS Plans To Award 10 New Institutional Grants For Up to $200,000 A Year In Cause And Prevention

November 16, 1979

NCI Advisors Approve Three New Grant Programs; RFA, PA Available.

July 5, 2002

Professional Societies: Three Groups To File brief In Fisher’s Appeal

October 11, 1996